XSHG
600746
Market cap1.24bUSD
Oct 09, Last price
7.56CNY
1D
5.29%
1Q
43.45%
Jan 2017
-39.76%
Name
Jiangsu SOPO Chemical Co.
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating both domestically within China and across global markets, Jiangsu SOPO Chemical Co. Ltd. specializes in the production and distribution of various chemical products. Its product portfolio includes acetic acid and its derivatives, which find applications in sectors such as dyes, textile printing, film production, solvents, pharmaceuticals, and pesticides. Additionally, the company supplies ethyl acetate, a vital organic chemical raw material. This compound is utilized in the manufacturing of paints, adhesives, ethyl celluloses, synthetic leathers, linoleum colorants, and artificial fibers; it also functions as a bonding agent in printing inks and as a crucial process solvent for organic chemical synthesis. Another offering is methyl alcohol, essential for the chemical and plastics industries, among others. Furthermore, Jiangsu SOPO produces ADC foaming agents, instrumental in the frothing processes for materials like EVA, PE, natural rubber, and PVC + NBR blends. The company's range extends to sulfuric acid products, serving chemical manufacturing, pharmaceuticals, and oil refining sectors. Other key chemicals include chlorinated benzene, fatty alcohol, and chloroacetic acid. Established in 1996, the company maintains its headquarters in Zhenjiang, located in the People's Republic of China.
Key people
Liming Fan
Vice Chairman of the Board · since 2018
Yunxia Sun
Deputy General Manager · since 2003
Guolin Fan
Secretary of the Board · since 2018
Zonggui Hu
Chairman of the Board · since 2017
Kehe Ma
General Manager, Director · since 2018
Ping Chen
Independent Director · since 2011
Lirong Mo
Independent Director · since 2011
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||